Entergy Mississippi, Inc. 1M BD 66 EMP
18.33 USD -0.12 (-0.65%)
At closeNov 10, 2026, 4:00 PM EST
18.33 0.00 0.00%
After hours · Nov 10, 4:00 PM ET
18.30 Day range 18.35
17.99 52-week range 21.15
- YTD
- -12.34%
- 1 year
- -12.34%
News
reuters.com Poland's EMP teams up with Foxconn to build EV manufacturing hub State-backed ElectroMobility Poland said Thursday it will partner with Taiwan's Foxconn to develop an electric vehicle production and research hub in southern Poland, advancing plans to create a…
globenewswire.com AtaiBeckley Announces Additional Phase 2a Results for EMP-01 (oral R-MDMA) Showing Large and Consistent Improvements in Social Anxiety Disorder NEW YORK, April 22, 2026 (GLOBE NEWSWIRE) -- AtaiBeckley Inc. (NASDAQ: ATAI) (“AtaiBeckley” or “Company”), a clinical-stage biotechnology company on a mission to transform patient outcomes by…
newsfilecorp.com Ernie Williams' "Wired for Disaster" Hits #1 on Amazon, Offering a Practical Guide to Surviving and Rebuilding After an EMP Event Summary: Author and preparedness expert Ernie Williams' newly released book, "Wired for Disaster: How to Prepare for and Navigate a Post-EMP World," has reached #1 in multiple Amazon categories. The…
seekingalpha.com Empire Company Limited (EMP.A:CA) Q3 2026 Earnings Call Transcript Empire Company Limited (EMP.A:CA) Q3 2026 Earnings Call Transcript
globenewswire.com AtaiBeckley Announces Positive Topline Results from an Exploratory Phase 2a Trial of EMP-01 (oral R-MDMA) in Social Anxiety Disorder EMP-01 met its primary objective on safety and tolerability, demonstrating a generally favorable and manageable safety and tolerability profile EMP-01 demonstrated a clinically meaningful…
seekingalpha.com Empire Company Limited (EMP.A:CA) Q2 2026 Earnings Call Transcript Empire Company Limited (EMP.A:CA) Q2 2026 Earnings Call Transcript
proactiveinvestors.com AtaiBeckley receives new US patent for oral R-MDMA formulation EMP-01 AtaiBeckley NV (NASDAQ:ATAI, XETRA:9VC) announced that the US Patent and Trademark Office has granted a new patent covering EMP-01, its oral R-MDMA formulation. The company said that the patent…
seekingalpha.com Empire Company Limited (EMP.A:CA) Q1 2026 Earnings Call Transcript Empire Company Limited (EMP.A:CA) Q1 2026 Earnings Call September 11, 2025 8:30 AM EDT Company Participants Katie Brine - Director of Investor Relations Michael Medline - President, CEO & Director…
seekingalpha.com Empire Company Limited (EMLAF) Q4 2025 Earnings Call Transcript Empire Company Limited (OTCPK:EMLAF) Q4 2025 Earnings Conference Call June 19, 2025 8:30 AM ET Company Participants Constantine Pefanis - Executive VP & CFO Katie Brine - Director of Investor…
proactiveinvestors.com atai Life Sciences doses first patient in Phase 2 social anxiety trial atai Life Sciences (NASDAQ:ATAI, ETR:9VC) announced that it has dosed the first patient in its Phase 2 clinical trial of EMP-01 for the treatment of social anxiety disorder (SAD). EMP-01, an oral…
globenewswire.com atai Life Sciences Announces First Patient Dosed in Phase 2 Study of EMP-01 for the Treatment of Social Anxiety Disorder - In a Phase 1 study, EMP-01 (oral R-MDMA) demonstrated a unique, dose-dependent subjective effect profile that was generally found to be more similar to classical psychedelics than to racemic MDMA
seekingalpha.com Empire Company Limited (EMLAF) Q3 2025 Earnings Call Transcript Empire Company Limited (OTCPK:EMLAF) Q3 2025 Earnings Conference Call March 13, 2025 8:30 AM ET Company Participants Katie Brine - VP, IR Michael Medline - President and CEO Matt Reindel - CFO Pierre…
seekingalpha.com Empire Company Limited (EMLAF) Q2 2025 Earnings Call Transcript Call Start: 12:00 January 1, 0000 12:46 PM ET Empire Company Limited (OTCPK:EMLAF) Q2 2025 Earnings Conference Call December 12, 2024, 12:00 PM ET Company Participants Katie Brine - IR, Treasury &…
seekingalpha.com Empire Company Limited (EMLAF) Q1 2025 Earnings Call Transcript Empire Company Limited (OTCPK:EMLAF) Q1 2025 Earnings Conference Call September 12, 2024 1:00 PM ET Corporate Participants Katie Brine - VP, IR Michael Medline - President and Chief Executive Officer…
seekingalpha.com Empire Company Limited (EMLAF) Q4 2024 Earnings Call Transcript Empire Company Limited (OTCPK:EMLAF) Q4 2024 Earnings Conference Call June 20, 2024 11:00 AM ET Company Participants Katie Brine - VP, IR Michael Medline - President and CEO Matt Reindel - CFO Pierre…
https://www.businesswire.com Walker & Dunlop Arranges $100 Million+ Construction Loan for Multifamily Project in Brooklyn BETHESDA, Md.--(BUSINESS WIRE)--Walker & Dunlop, Inc. announced today that it arranged a $110,000,000 loan to facilitate the construction of 880 Atlantic Avenue, a 246-unit Class-A multifamily…
seekingalpha.com Empire Company Limited (EMLAF) Q3 2024 Earnings Call Transcript Empire Company Limited (EMLAF) Q3 2024 Earnings Call Transcript
seekingalpha.com Empire: 2024 Upside From Valuation Normalizing Empire has faced execution issues and a cybersecurity incident, but shares have re-rated to a good buy zone with long-term potential. The company has shown signs of a turnaround, with improvements in…
seekingalpha.com Empire Company Limited (EMLAF) Q2 2024 Earnings Call Transcript Empire Company Limited (OTCPK:EMLAF) Q2 2024 Earnings Conference Call December 14, 2023 12:00 PM ET Company Participants Katie Brine - Vice President, Treasury, Investor Relations, ESG Finance,…
seekingalpha.com Empire Company Limited (EMLAF) Q1 2024 Earnings Call Transcript Empire Company Limited (OTCPK:EMLAF) Q1 2024 Results Conference Call September 14, 2023 1:00 PM ET Company Participants Katie Brine - VP Investor Relations Michael Medline - President and Chief…